Kratom's Double-Edged Nature: As Calls to Poison Centers Skyrocket, What's the Real Story?

It seems like every now and then, a natural remedy bursts onto the scene, promising a world of relief. But sometimes, these promises come with a shadow of concern. Take kratom, for instance – a plant hailing from Southeast Asia. While many vouch for its benefits, especially for pain management and opioid withdrawal, a look at recent trends paints a more complicated picture. In fact, fears surrounding its use are truly materializing, with poison control centers across the U.S. reporting an absolutely staggering increase in calls related to kratom exposure.

When you look at the numbers, it’s quite a jump. Between 2011 and 2017 alone, calls to poison centers concerning kratom exposures shot up by over 1,200 percent. Think about that: from just 13 calls in 2011 to a whopping 682 in 2017. And the trend didn't stop there; by September 2018, the total number of reported exposures since 2011 had climbed past 1,800. What's even more concerning is the severity of these incidents. Over 40 percent of these exposures were serious enough to be classified as 'major,' with a small but significant percentage being life-threatening. Tragically, at least 11 deaths have also been associated with kratom, though often in cases where other substances were also involved.

Health officials, especially those at the U.S. Food and Drug Administration (FDA), are not mincing words. They’ve issued stern warnings, advising consumers to steer clear of kratom entirely. Why such a strong stance? Well, the FDA points to compounds within the plant, specifically mitragynine and 7-hydroxymitragynine, which act on the brain's opioid receptors. This is precisely why many users find it helps with pain or opioid withdrawal symptoms. However, it also means kratom carries similar risks to opioids, including addiction, dependency, and severe withdrawal symptoms. FDA Commissioner Scott Gottlieb, at the time, openly called kratom an opioid, emphasizing its potential for danger and abuse.

Yet, the story isn't quite so one-sided. Advocates for kratom, like the American Kratom Association (AKA), argue vehemently against an outright ban. They champion it as a natural, potentially life-saving alternative for individuals struggling with chronic pain or battling opioid addiction, often asserting it’s safer than prescription opioids. Their concern is that scheduling kratom as a controlled substance would only push users into the black market or back to more dangerous, illicit drugs, exacerbating the very opioid crisis the FDA aims to combat. It’s a bit of a tangled mess, isn’t it?

Part of the problem lies in the Wild West nature of its availability. Kratom is sold in various forms – powders, capsules, teas, extracts – often online or in smoke shops, with virtually no standardized dosing or quality control. This lack of regulation means consumers often have no idea about the purity, potency, or potential contaminants in the products they’re taking. This uncertainty, coupled with insufficient scientific research into its long-term effects, optimal dosages, and potential drug interactions, creates a significant public health challenge. While the DEA attempted to classify it as a Schedule I substance in 2016, public outcry led them to withdraw the proposal, leaving its legal status a patchwork across different states.

Ultimately, the rise in poison control calls serves as a stark reminder that while some individuals may find kratom helpful, its unregulated status and the serious risks identified by health authorities cannot be ignored. The ongoing debate underscores a critical need for more robust scientific inquiry and clear, consistent regulation. Until then, for anyone considering kratom, proceeding with extreme caution and seeking professional medical advice seems like the only truly responsible path.